Summary A new method for more timely monitoring of cancer patient survival was employed to assess progress in 5-year survival of breast cancer patients in Saarland, Germany, between 1980-84 and 1990-94. Five-year relative survival gradually increased from 68.8% to 73.5%. Improvements were most pronounced among age groups 50-59 and 60-69. The latter had the highest 5-year relative survival (77.1%) al. 1992. 1997). More than 90%c of breast cancers were verified histologically, and the proportion of cases notified by death certificates only has been below 5% since the early 1970s. Using a three-source (notifications from clinicians, pathologists and death certificates) capture-recapture approach. completeness of the Saarland cancer registry has recently been estimated to have been above 95% since the early 1970s (Brenner et al. 1994 ).
. It has been suggested that the recent change in mortality trends may be due to increased survival resulting from improved management and treatment of women with breast cancer (Beral et al. 1995 : Baum. 1995 . A slight improvement or no change in 5-year relative survival for patients diagnosed in 1983-85 compared with patients diagnosed in 1978-80 was seen for various European countries in the EUROCARE study (Berrino et al. 1995) . but more recent population-based survival data are very sparse.
In this paper. we report on recent trends of survival of breast cancer in Saarland. Germany. A new method of monitoring survival was employed that allows more timely detection of recent trends (Brenner and Gefeller. 1996) .
MATERIAL AND METHODS
This analysis is based on data of the population-based cancer registry of Saarland. Germany Cancer (Waterhouse et al. 1982 : Muir et al. 1988 : Parkin et al. 1992 . 1997 ). More than 90%c of breast cancers were verified histologically, and the proportion of cases notified by death certificates only has been below 5% since the early 1970s. Using a three-source (notifications from clinicians, pathologists and death certificates) capture-recapture approach. completeness of the Saarland cancer registry has recently been estimated to have been above 95% since the early 1970s (Brenner et al. 1994 ).
The present analysis includes women with a first diagnosis of breast cancer (ICD-9 position 174) below age 80 between 1975 and 1994 who were followed with respect to vital status by 31 December 1994. Patients who were notified to the cancer registry by death certificate only were excluded from the analysis.
Analysis of survival was performed using a new approach. denoted 'period monitoring', that allows more timely detection of changes in survival rates. The approach is described in detail elsewhere (Brenner and Gefeller, 1996) . Briefly. the principle is as follows: cumulative survival rates are calculated by calendar periods of observation rather than by cohorts of patients defined by common calender periods of diagnosis. For example. using 31 December. 1994 as closing date of follow-up, a recent estimate of 5-year cumulative survival for the period 1990-94 is obtained by exclusive consideration of the survival experience (during the first 5 years following diagnosis) within that period of patients diagnosed in 1985-94. By contrast, the most recent estimate of 5-year survival using traditional 'cohort monitoring' of survival would reflect the survival experience during 1985-94 of patients diagnosed in 1985-89. If survival rates are constant over time. cohort monitoring and period monitoring yield identical results. It has been shown, however, that the period monitoring approach enables much more timely detection of changes in long-term cumulative survival rates than traditional cohort monitoring of sur ival.
In this study. absolute and relative 5-year cumulative survival rates are estimated by the modified life table method described by Saarland, Gerrnany, between 1980-84 and 1990-94 . All estimates are derived by the pernod-montonng approach (Brenner and Gefeller, 1996) Brenner and Gefeller (1996) for calendar periods 1980-84. 1985-89 and 1990-94 to disclose recent trends in survival.
Relative survival rates quantify the ratio of observed survival rates to the expected survival rates (Ederer et al. 1961 (Greenwood. 1926 Figure 1 . which depicts survival functions bv age at diagnosis for calendar periods 1980-84 and 1990-94. Whereas similar improvements in prognosis during the first Xears following diagnosis are seen in all age groups. the more faxourable dex elopment of sun ix al in age groups 50-59 and 60-69 than in the other age groups mainly exolved in later Xears of follow--up.
Finally. the period estimates of 5-xear cumulative relative sun-ix al for all age groups combined for periods 1980-84. 1985-89 and 1990-94 Group. 1992) . Detailed data on treatment are not available in the Saarland cancer registry. Given inclusion of tamoxifen therapy in treatment recommendations in Germany in recent years, it appears plausible, however, that improvements in survival may at least partly be due to increased use of this therapy. Nevertheless, other factors, such as a change in the natural history of the disease, might also play a role (Joensuu and Toikkanen. 1991 ) .
Regardless of their origin. the most recent improvements in survival disclosed in this paper should help to prevent clinicians and their patients from being discouraged by outdated overly pessimistic survival statistics. Despite considerable improvement however, our up-to-date estimates of 5-year relative survival in Germany still lag behind those observed for patients diagnosed in other countries, such as Switzerland. Finland and the United States (McIntosh. 1992 : Berrino et al. 1995 . This suggests that further improvement should be possible.
